Creative Medical Technology Holdings (CELZ) Issues Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Creative Medical Technology Holdings Provides Corporate Update
July 10, 2024 8:30 AM EDTPHOENIX, July 10, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (Creative Medical Technology or the Company) (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today provided a corporate update highlighting recent developments of note.
As we enter the second half of 2024, it is an opportune time to reflect on our recent achievements, said Timothy Warbington, Chief Executive Officer. Many of our successes thus far in 2024 were the result of investments we have made in prior years combined with our... More
